Telesis Bio Stock Is Soaring Wednesday: What's Going On?
Telesis Bio Stock Is Soaring Wednesday: What's Going On?
Telesis Bio Inc (NASDAQ:TBIO) shares are soaring in extended trading Wednesday after the company announced a partnership to revolutionize DNA and mRNA synthesis.
Telesis生物公司(NASDAQ:TBIO)股票在週三盤後交易中飆升,因該公司宣佈與合作伙伴合作,革新DNA和mRNA合成。
What Happened: Telesis Bio reached a new partnership with laboratory automation and innovation company Beckman Coulter Life Sciences to create efficient and scalable biofoundries and deliver solutions for DNA synthesis.
發生了什麼: Telesis生物與實驗室自動化和創新公司貝克曼庫爾特生命科學達成了新合作,以創建高效可擴展的生物工廠,併爲DNA合成提供解決方案。
The partnership will integrate Telesis Bio's Gibson SOLA Enzymatic Synthesis technology with Beckman Coulter's new Biomek Echo One System, further expanding its flexibility to synthesize biology.
該合作將Telesis生物的Gibson SOLA酶合成技術與Beckman Coulter的新Biomek Echo One系統相結合,進一步擴展其生物合成靈活性。
"This partnership marks a significant milestone in advancing synthetic biology. By integrating Gibson SOLA's high-fidelity, scalable, and non-toxic DNA synthesis capabilities with Beckman Coulter Life Sciences automation expertise, we are setting a new standard for on-premises biofoundries," said Eric Esser, CEO of Telesis Bio.
「這一合作標誌着合成生物學的重要里程碑。通過將Gibson SOLA的高保真、可擴展和無毒的DNA合成能力與貝克曼庫爾特生命科學的自動化專業知識相結合,我們正在爲現場生物工廠樹立新的標準,」 Telesis Bio首席執行官埃裏克·埃瑟說。
"This collaboration empowers researchers to greatly improve productivity through faster, more reliable and innovative solutions, driving forward the next generation of therapeutic and diagnostic advancements."
「這一合作使研究人員能夠通過更快速、更可靠和更創新的解決方案大大提高生產率,推動下一代治療和診斷進步的發展。」
Telesis Bio provides non-toxic, high-fidelity and scalable DNA synthesis, empowering scientists to create novel, synthetic biology-enabled solutions.
Telesis生物提供無毒、高保真和可擴展的DNA合成,幫助科學家創造新穎的、合成生物學啓用的解決方案。
Telesis Bio is considered a low-float stock with approximately 406,000 shares available for public trading, according to Benzinga Pro. It also had a market cap of less than $5 million as of Wednesday's close. Low-float, micro-cap stocks often trade with elevated volatility, which may help explain some of Telesis Bio's massive move after the bell.
根據Benzinga Pro的數據,Telesis生物被認爲是一隻低浮動股,大約有406,000股可供公開交易,截至週三收盤時的市值不到500萬美元。低浮動、微型股通常具有較高的波動性,這可能有助於解釋鈴響後Telesis生物的大幅上漲中的一些原因。
TBIO Price Action: Telesis Bio shares were up 110.02% at $4.87 in after-hours trading Wednesday, according to Benzinga Pro.
TBIO價格走勢:據Benzinga Pro報道,Telesis生物股票週三盤後交易中上漲110.02%,報4.87美元。
This illustration was generated using artificial intelligence via Midjourney.
此插圖是通過Midjourney使用人工智能生成的。